2016 Annual Report

Woman vaccinating a young girl.

From PATH’s president and board chair

Dear PATH friends, supporters, and colleagues:

Health equity is the bedrock of economic opportunity, social justice, and political stability. At PATH, we believe access to high-quality health care shouldn’t depend on your gender, your income, or where you were born.

PATH is redoubling our commitment to ensuring that everyone has an equal chance for a healthy life. Even as we face a new climate of uncertainty about the future of global health funding and evidence-based science, we feel a sense of great optimism about what’s possible.

New technologies, innovative partnerships, and renewed global commitments to improving the health of the world’s women and children are unleashing an unstoppable momentum.

As we celebrate PATH’s 40th anniversary this year, we are proud of the contributions we have made to global health with your support. In 2016, PATH advanced new vaccines, drug treatments, and diagnostics; expanded access to nutrition innovations and family planning options; helped countries strengthen health systems and prepare for future epidemics; and advocated for funding and policies that support scientific research and innovation.

Together with our partners and generous donors, PATH reaches an average of 150 million people per year in more than 70 countries through this lifesaving work.

All this and more is possible because of your support and partnership. Thank you for your commitment to a world where innovation ensures that health is within reach for everyone.

With gratitude,

Steve Davis signature

Steve Davis
President and CEO

Dean Allen signature

Dean Allen
Chair, Board of Directors

Photo: PATH/Rocky Prajapati

Thank you to our supporters

Nothing PATH does would be possible without our supporters—key partners in our work to accelerate lifesaving innovations. We are deeply grateful for the many individual donors, foundations, corporations, and institutions that supported PATH’s work in 2016.

Charity Navigator 4-star charity: 12 years at 4 stars.

Finances

2016 financial summary

Revenue (in thousands)
Foundations*$178,833
US government 102,818
Other governments, nongovernmental organizations (NGOs), multilaterals 32,500
Individuals/other 13,183
Corporations 3,120
Investments 1,470
Total revenue $331,924
Expenses (in thousands)
Program-related:
Public health$64,915
Essential medicines41,213
International development37,668
Technology development and introduction16,976
Cross-program initiatives12,062
Program development3,667
Subawards to program partners102,940
Subtotal program-related$279,441
Administrative$41,677
Fundraising4,143
Total expenses$325,261
Assets (in thousands)
Cash and cash equivalents$103,862
Invested grant funds181,697
Contributions and awards receivable248,430
Other21,417
Total assets$555,226
Liabilities and net assets (in thousands)
Total liabilities $54,899
Net assets:
Temporarily restricted$470,882
Unrestricted26,051
Permanently restricted3,394
Total net assets $500,327
Total liabilities and net assets$555,226

Leadership

Board of Directors


* Retired from board service in 2016.

Executive Team

  • Steve Davis, MA, JD
    President and CEO
  • Amie Batson, MBA
    Chief Strategy Officer
    Vice President, Strategy and Learning
  • Kathy Cahill, MPH
    Vice President, International Development
  • David Fleming, MD
    Vice President, Public Health
  • David C. Kaslow, MD
    Vice President, Essential Medicines
    Director, Center for Vaccine Innovation and Access
  • Dan Laster, JD
    Chief Operating Officer and General Counsel, Operations and Research Affairs
  • Mark D. Murray
    Vice President, Global Engagement and Communications
  • Kathryn O’Driscoll
    Chief Human Resources Officer
  • Olivia Polius
    Chief Financial Officer
    Vice President, Finance, Technology, and Infrastructure
  • Praveen Raja, PhD
    Vice President, Technology Development and Introduction

Program Leaders

International Development

  • Mona Byrkit, MPH
    Mekong Region
  • Craig Friderichs, MD
    South Africa
  • Kateryna (Katya) Gamazina, MD
    Ukraine
  • Philippe Guinot, MBA
    Europe and West Africa
  • Trad Hatton, MA, MHS
    Democratic Republic of the Congo
  • Neeraj Jain, MBA
    India
  • Tirsit Grishaw Legesse, MSc
    Ethiopia
  • Nanthalile Mugala, MD, MMed
    Zambia
  • Emmanuel Mugisha, PhD, MPH
    Uganda
  • Rikka Trangsrud, MA
    Kenya
  • Jason Walton, MPP
    International Development
  • YanXiang (Michael) Wang, MBA
    China
  • To be hired
    Tanzania

Essential Medicines

  • Deborah Atherly, PhD
    Policy, Access, and Introduction, Center for Vaccine Innovation and Access
  • Ashley Birkett, PhD
    Malaria Vaccine Initiative
    Malaria Disease Area, Center for Vaccine Innovation and Access
  • Frederick J. Cassels, PhD
    Enteric & Diarrheal Diseases, Center for Vaccine Innovation and Access
  • Jorge Flores, MD
    Clinical, Center for Vaccine Innovation and Access
  • Bruce L. Innis, MD, FIDSA
    Respiratory Infections & Maternal Immunizations, Center for Vaccine Innovation and Access
  • John Konz, PhD
    Integrated Portfolio and Financial Management, Center for Vaccine Innovation and Access
  • Harshvardhan (Hersh) Mehta, PhD
    Chemistry Manufacturing & Controls, Center for Vaccine Innovation and Access
  • Karen Midthun, MD
    Regulatory, Center for Vaccine Innovation and Access

  • Jessica Milman, MPH
    Office of Essential Medicines
  • David Shoultz, PhD, MS, MBA
    Drug Development

Public health

  • Martha Brady, MS
    Reproductive Health
  • Cyril Engmann, MD, FAAP
    Maternal, Newborn, and Child Health and Nutrition
  • Katharine Kreis, MPH
    Nutrition Innovations
  • Helen McGuire, MHA
    Noncommunicable Diseases
  • Bindiya Patel, MPA
    Public Health
  • Dykki Settle
    Digital Health Solutions
  • Larry Slutsker, MD, MPH
    Malaria and Neglected Tropical Diseases
    Center for Malaria Control and Elimination
  • Johannes van Dam, MD, MSc
    Health Systems Innovation and Delivery
    HIV/AIDS and Tuberculosis

Technology Development and Introduction

  • Tala de los Santos, MS, MBA
    Diagnostics
  • Kim Kertson, MBA (interim)
    Devices and Tools

PATH’s global presence

PATH works in more than 70 countries to accelerate innovation that saves lives and improves health, especially among women and children.

Our country-based projects tackle top-priority health challenges at the local and national levels in collaboration with governments, private-sector partners, and others. Our global partnerships address international-level health priorities, policies, and financing in collaboration with policymakers, funders, and others.

World map showing PATH project, partnership, and office locations.
Country-based projects Global partnerships PATH office

Office locations

  • Belgium | Brussels
  • China | Beijing
  • Democratic Republic of the Congo | Kinshasa, Kisangani, Kolwezi, Lubumbashi
  • Ethiopia | Addis Ababa, Injibara
  • Ghana | Accra
  • India | Lucknow, Mumbai, New Delhi
  • Kenya | Bungoma, Busia, Kakamega, Kisumu, Migori, Nairobi, Nyamira, Oyugis
  • Malawi | Lilongwe
  • Mozambique | Maputo, Matola
  • Myanmar | Yangon
  • Peru | Lima
  • Senegal | Dakar
  • South Africa | Johannesburg
  • Switzerland | Geneva
  • Tanzania | Arusha, Dar es Salaam
  • Uganda | Kampala, Mbale, Mbarara
  • Ukraine | Kyiv
  • United States | San Francisco, Seattle (headquarters), Washington, DC
  • Vietnam | Hanoi, Ho Chi Minh City
  • Zambia | Livingstone, Lusaka